Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

76.86 +0.42 (+0.55%)
Streaming Delayed Price Updated: 2:06 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
News headline image
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Edwards Lifesciences Stock ↗
 
Via Benzinga
News headline image
How Do Investors Really Feel About Edwards Lifesciences? ↗
 
Via Benzinga
News headline image
EDWARDS LIFESCIENCES CORP (NYSE:EW) - A Technical Breakout Candidate Worth Watching ↗
EDWARDS LIFESCIENCES CORP (NYSE:EW) shows strong technicals and a high-quality setup, making it a potential breakout candidate for traders. 
Via Chartmill
News headline image
P/E Ratio Insights for Edwards Lifesciences ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 23, 2025 ↗
 
Via Benzinga
News headline image
Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens ↗
The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals... 
Via Stocktwits
News headline image
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott ↗
The company said the regulatory path forward for one of its key systems is too murky to pursue. 
Via Investor's Business Daily
News headline image
Assessing Edwards Lifesciences: Insights From 6 Financial Analysts ↗
 
Via Benzinga
News headline image
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
What's going on in today's pre-market session: S&P500 movers ↗
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session. 
Via Chartmill
News headline image
Edwards Lifesciences Corp (NYSE:EW) - A Technical Breakout Candidate Worth Watching ↗
Edwards Lifesciences (NYSE:EW) shows strong technicals and a consolidation pattern, making it a breakout candidate. Resistance at $76.76 could signal further upside if broken. 
Via Chartmill
News headline image
What's Driving the Market Sentiment Around Edwards Lifesciences? ↗
 
Via Benzinga
News headline image
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
In today's session, there are S&P500 stocks with remarkable trading volume. ↗
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. 
Via Chartmill
News headline image
Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens ↗
Edwards Lifesciences raised 2025 revenue forecast after Q1 results beat EPS estimates and TMTT sales jumped 58% amid strong global demand. 
Via Benzinga
News headline image
What's going on in today's session: S&P500 movers ↗
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday? ↗
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade... 
Via Benzinga
Topics Government World Trade
News headline image
This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
Thursday's pre-market session: top gainers and losers in the S&P500 index ↗
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements. 
Via Chartmill
News headline image
Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat ↗
Edwards Lifesciences stock was flat late Wednesday after the medtech company beat profit views and delivered in-line sales. 
Via Investor's Business Daily
Topics ETFs
News headline image
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday? ↗
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
News headline image
A Look at Edwards Lifesciences's Upcoming Earnings Report ↗
 
Via Benzinga
News headline image
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Is Edwards Lifesciences Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
From Edwards Lifesciences Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.